{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:24:46Z","timestamp":1770665086065,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10552-025-02093-1","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:15:32Z","timestamp":1766819732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Madeline C.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandini","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha I.","family":"Huda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris I.","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veda Naga Priya","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utsav","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"issue":"11","key":"2093_CR1","first-page":"937","volume":"93","author":"CA Doubeni","year":"2016","unstructured":"Doubeni CA, Doubeni AR, Myers AE (2016) Diagnosis and management of ovarian cancer. Am Fam Physician 93(11):937\u2013944","journal-title":"Am Fam Physician"},{"key":"2093_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12030397","author":"BO Grabarek","year":"2023","unstructured":"Grabarek BO, Ossowski P, Czarniecka J, Ozog M, Prucnal J, Dziuba I et al (2023) Detection and genotyping of human papillomavirus (HPV16\/18), Epstein-Barr virus (EBV), and human cytomegalovirus (HCMV) in endometrial endometroid and ovarian cancers. Pathogens. https:\/\/doi.org\/10.3390\/pathogens12030397","journal-title":"Pathogens"},{"issue":"1","key":"2093_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/aji.70046","volume":"93","author":"N Goel","year":"2025","unstructured":"Goel N, Baker MC, Aboujaoude MT, Diaz MJ, Jain R, Huda TI et al (2025) Better outcomes for ovarian cancer associated with the detection of anti-EBV TCR CDR3s: potential relevance to diffuse large B-cell lymphoma. Am J Reprod Immunol 93(1):e70046. https:\/\/doi.org\/10.1111\/aji.70046","journal-title":"Am J Reprod Immunol"},{"key":"2093_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101674","volume":"54","author":"M Donzel","year":"2022","unstructured":"Donzel M, Bonjour M, Combes JD, Broussais F, Sesques P, Traverse-Glehen A et al (2022) Lymphomas associated with Epstein-Barr virus infection in 2020: results from a large, unselected case series in France. EClinicalMedicine 54:101674. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101674","journal-title":"EClinicalMedicine"},{"key":"2093_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-019-0236-7","volume":"14","author":"L Hammerl","year":"2019","unstructured":"Hammerl L, Colombet M, Rochford R, Ogwang DM, Parkin DM (2019) The burden of Burkitt lymphoma in Africa. Infect Agent Cancer 14:17. https:\/\/doi.org\/10.1186\/s13027-019-0236-7","journal-title":"Infect Agent Cancer"},{"key":"2093_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CIN.S35784","volume":"15","author":"TR Gill","year":"2016","unstructured":"Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G (2016) Detection of productively rearranged TcR-\u03b1 V\u2013J sequences in TCGA exome files: implications for tumor immunoscoring and recovery of antitumor T-cells. Cancer Inform 15:23\u201328. https:\/\/doi.org\/10.4137\/CIN.S35784","journal-title":"Cancer Inform"},{"issue":"3","key":"2093_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/21645515.2016.1246095","volume":"13","author":"WL Tong","year":"2017","unstructured":"Tong WL, Tu YN, Samy MD, Sexton WJ, Blanck G (2017) Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother 13(3):501\u2013506. https:\/\/doi.org\/10.1080\/21645515.2016.1246095","journal-title":"Hum Vaccin Immunother"},{"key":"2093_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2022.08.001","volume":"150","author":"RA Eakins","year":"2022","unstructured":"Eakins RA, Chobrutskiy A, Teer JK, Patel DN, Hsiang M, Huda TI et al (2022) Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3\/6 correlates with increased melanoma survival: potential relevance to MAGE vaccine auto-reactivity. Mol Immunol 150:58\u201366. https:\/\/doi.org\/10.1016\/j.molimm.2022.08.001","journal-title":"Mol Immunol"},{"issue":"3","key":"2093_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11060-018-03001-1","volume":"140","author":"BI Chobrutskiy","year":"2018","unstructured":"Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G (2018) Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol 140(3):697\u2013704. https:\/\/doi.org\/10.1007\/s11060-018-03001-1","journal-title":"J Neurooncol"},{"issue":"4","key":"2093_CR10","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH et al (2018) The immune landscape of cancer. Immunity 48(4):812\u2013830. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"key":"2093_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-0716-2712-9_13","volume":"2574","author":"W Chronister","year":"2022","unstructured":"Chronister W, Sette A, Peters B (2022) Epitope-specific T cell receptor data and tools in the immune epitope database. Methods Mol Biol 2574:267\u2013280. https:\/\/doi.org\/10.1007\/978-1-0716-2712-9_13","journal-title":"Methods Mol Biol"},{"issue":"269","key":"2093_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"5","key":"2093_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"issue":"4","key":"2093_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","volume":"130","author":"MA Jensen","year":"2017","unstructured":"Jensen MA, Ferretti V, Grossman RL, Staudt LM (2017) The NCI genomic data commons as an engine for precision medicine. Blood 130(4):453\u2013459. https:\/\/doi.org\/10.1182\/blood-2017-03-735654","journal-title":"Blood"},{"issue":"12","key":"2093_CR15","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB et al (2019) Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133(12):1313\u20131324. https:\/\/doi.org\/10.1182\/blood-2018-09-871418","journal-title":"Blood"},{"key":"2093_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molimm.2021.02.026","volume":"135","author":"BI Chobrutskiy","year":"2021","unstructured":"Chobrutskiy BI, Chobrutskiy A, Zaman S, Yeagley M, Huda TI, Blanck G (2021) High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer. Mol Immunol 135:247\u2013253. https:\/\/doi.org\/10.1016\/j.molimm.2021.02.026","journal-title":"Mol Immunol"},{"key":"2093_CR17","doi-asserted-by":"publisher","first-page":"117693512311772","DOI":"10.1177\/11769351231177269","volume":"22","author":"N Pakasticali","year":"2023","unstructured":"Pakasticali N, Chobrutskiy A, Patel DN, Hsiang M, Zaman S, Cios KJ et al (2023) Chemical complementarity of breast cancer resident, T-cell receptor CDR3 domains and the cancer antigen, ARMC3, is associated with higher levels of survival and granzyme expression. Cancer Inform 22:11769351231177268. https:\/\/doi.org\/10.1177\/11769351231177269","journal-title":"Cancer Inform"},{"issue":"8","key":"2093_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003200","volume":"9","author":"O Manor","year":"2013","unstructured":"Manor O, Segal E (2013) Predicting disease risk using bootstrap ranking and classification algorithms. PLoS Comput Biol 9(8):e1003200. https:\/\/doi.org\/10.1371\/journal.pcbi.1003200","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"2093_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"HY Kim","year":"2017","unstructured":"Kim HY (2017) Statistical notes for clinical researchers: chi-squared test and Fisher\u2019s exact test. Restor Dent Endod 42(2):152\u2013155. https:\/\/doi.org\/10.5395\/rde.2017.42.2.152","journal-title":"Restor Dent Endod"},{"key":"2093_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/1176935117725727","volume":"16","author":"B Ray","year":"2017","unstructured":"Ray B, Liu W, Fenyo D (2017) Adaptive multiview nonnegative matrix factorization algorithm for integration of multimodal biomedical data. Cancer Inform 16:1176935117725727. https:\/\/doi.org\/10.1177\/1176935117725727","journal-title":"Cancer Inform"},{"key":"2093_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/23247096231154641","volume":"11","author":"M Urella","year":"2023","unstructured":"Urella M, Nwanwene K, Sidda A, Pacioles T (2023) A rare case of ovarian double-hit\/diffuse large B-cell lymphoma: a case report and review of literature. J Investig Med High Impact Case Rep 11:23247096231154641. https:\/\/doi.org\/10.1177\/23247096231154641","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"3","key":"2093_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ygyno.2022.07.004","volume":"166","author":"O Pitiyarachchi","year":"2022","unstructured":"Pitiyarachchi O, Friedlander M, Java JJ, Chan JK, Armstrong DK, Markman M et al (2022) What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (\u226510 years) survivors in NRG\/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecol Oncol 166(3):410\u2013416. https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2093_CR23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.18295\/squmj.1.2023.002","volume":"23","author":"RA Sakr","year":"2023","unstructured":"Sakr RA, Nasr AA, Zineldin EI, Gouda MA (2023) Long-term survival in patients with cancers: surveillance, epidemiology and end results-based analysis. Sultan Qaboos Univ Med J 23(3):344\u2013350. https:\/\/doi.org\/10.18295\/squmj.1.2023.002","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"1-2","key":"2093_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mce.2013.05.016","volume":"375","author":"K Yakimchuk","year":"2013","unstructured":"Yakimchuk K, Jondal M, Okret S (2013) Estrogen receptor alpha and beta in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol 375(1\u20132):121\u2013129. https:\/\/doi.org\/10.1016\/j.mce.2013.05.016","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2093_CR25","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3109\/0284186X.2015.1026455","volume":"54","author":"G Hedstrom","year":"2015","unstructured":"Hedstrom G, Peterson S, Berglund M, Jerkeman M, Enblad G (2015) Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma\u2014a Swedish population-based study. Acta Oncol 54(6):924\u2013932. https:\/\/doi.org\/10.3109\/0284186X.2015.1026455","journal-title":"Acta Oncol"},{"issue":"2","key":"2093_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0609.2010.01541.x","volume":"86","author":"S Riihijarvi","year":"2011","unstructured":"Riihijarvi S, Taskinen M, Jerkeman M, Leppa S (2011) Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy. Eur J Haematol 86(2):124\u2013128. https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01541.x","journal-title":"Eur J Haematol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02093-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T04:00:32Z","timestamp":1770609632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02093-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02093-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The access to the indicated datasets was via NIH dbGaP approval numbers indicated in \u201c\n                      \n                      \u201d","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13"}}